[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100093930":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":69,"collaborators":20,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":77,"acronym":20,"eligibilityCriteria":78,"healthyVolunteers":75,"sex":79,"minAge":80,"maxAge":20,"enrollmentInfo":81,"targetDuration":20,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Interventional","EXPERIMENTAL","Endovascular Branched Stent-Graft: The investigational operation is done making small incisions in both groins and the right arm and placing a graft in the aorta through tubes that are inserted through the femoral and brachial arteries, than fastening it in position with metal springs(stents).",[13],"Device: Endovascular Branched Stent-Graft",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Endovascular Branched Stent-Graft","Industry manufactured branched stent-graft for treatment of TAAA\u002FPVAAA.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Warren J Gasper, MD","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","415 750 2115","warren.gasper@ucsf.edu",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},"Madeleine L Clinch","415-353-4367","Madeleine.Clinch@ucsf.edu",[35,54],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Division of Vascular Surgery, SFVAMC","RECRUITING","San Francisco","California","94121","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-122.41942,37.77493,{"lat":47,"lon":46},[50,51],{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"name":52,"role":53,"phone":20,"phoneExt":20,"email":20},"Linda M Reilly, MD","SUB_INVESTIGATOR",{"facility":55,"status":37,"city":38,"state":39,"zip":56,"country":41,"countryCode":42,"cosmosGeoPoint":57,"geoPoint":59,"contacts":60},"Division of Vascular Surgery, UCSF","94143",{"type":44,"coordinates":58},[46,47],{"lat":47,"lon":46},[61,62,63,65,67],{"name":52,"role":53,"phone":20,"phoneExt":20,"email":20},{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"name":64,"role":53,"phone":20,"phoneExt":20,"email":20},"Timothy AM Chuter, MD",{"name":66,"role":53,"phone":20,"phoneExt":20,"email":20},"Jade S Hiramoto, MD",{"name":68,"role":53,"phone":20,"phoneExt":20,"email":20},"Shant M Vartanian, MD",{"type":70,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"SPONSOR_INVESTIGATOR","Warren J. Gasper, MD","Associate Professor, Surgery","100093930","endovascular-exclusion-of-thoracoabdominal-andor-paravisceral-abdominal-aortic-aneurysm-100093930",false,"NCT00483249","Endovascular Exclusion of Thoracoabdominal and\u002For Paravisceral Abdominal Aortic Aneurysm","Inclusion Criteria\n\n1. Aortic aneurysms:\n\n   * greater than or equal to 6 cm in diameter in men,\n   * greater than or equal to 5.5 cm in diameter in women,\n   * and\u002For larger than 5 cm in diameter and enlarging at a rate of more than 5 mm\u002Fyear,\n   * and\u002For iliac aneurysms larger than 4 cm in diameter.\n2. Anticipated mortality comparable to published rates with conventional surgical treatment.\n3. Life expectancy more than 2 years.\n4. Ability to give informed consent.\n5. Willingness to comply with follow-up schedule.\n6. Suitable arterial anatomy for endovascular repair.\n\nExclusion Criteria\n\n1. Free rupture of the aneurysm.\n2. Pregnancy.\n3. Known allergy to Nitinol, stainless steel, or polyester.\n4. Unwillingness or inability to comply with the follow up schedule.\n5. Serious systemic or groin infection.\n6. Uncorrectable coagulopathy.","ALL","18 Years",{"count":82,"type":83},250,"ESTIMATED","INTERVENTIONAL",[86],"NA","This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.",[89,90],"Thoracoabdominal Aortic Aneurysm","Paravisceral Abdominal Aortic Aneurysm",[92,93,94,95,96,97],"Thoracoabdominal","Paravisceral","Aneurysm","Endovascular","Stent-Graft","Aorta","2026-03-03",{"date":100,"type":101},"2026-03-05","ACTUAL",{"date":103,"type":20},"2005-05",{"date":105,"type":83},"2027-12",{"name":71,"class":6},2]